{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:58:26Z","timestamp":1789775906223,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302447"],"award-info":[{"award-number":["82302447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172879"],"award-info":[{"award-number":["82172879"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ10096"],"award-info":[{"award-number":["2022JJ10096"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung adenocarcinoma (LUAD) remains a leading cause of cancer-related mortality worldwide, and understanding its molecular drivers is critical for improving therapeutic outcomes. SUMOylation is a form of post-translational modification that conjugates small ubiquitin-like modifier (SUMO) to specific lysine residues of target proteins. The sole SUMO E2-conjugating enzyme UBC9 is upregulated in multiple malignancies, yet its functional role and specific substrate in LUAD remain poorly defined. Here, we demonstrate that UBC9 is significantly elevated in LUAD tissues, and its high expression is associated with adverse clinic outcomes. Functional assays revealed that genetic ablation of UBC9 robustly suppresses LUAD cell proliferation, migration, invasion, and tumorigenesis both in vitro and in vivo. Through immunoprecipitation-mass spectrometry, we identified Coronin-1C (CORO1C), a master regulator of actin dynamics, as a key substrate of UBC9-mediated SUMOylation. Mechanistically, SUMOylation of CORO1C at lysine residues K19, K311, and K440 enhances its binding to actin-related protein 2 (Arp2) complex, promotes actin\u2011based cytoskeletal remodeling, and drives malignant cellular behaviors. Collectively, our work reveals a previously unrecognized regulatory axis in which UBC9\u2011dependent SUMOylation licenses CORO1C to orchestrate Arp2\/3\u2011mediated cytoskeletal dynamics, thereby advancing LUAD progression. These findings reveal CORO1C as a novel SUMOylation target in lung adenocarcinoma and offer new mechanistic insights into tumor cell motility, but also highlight a promising therapeutic avenue for treating advanced LUAD.<\/jats:p>","DOI":"10.1038\/s41419-026-08653-w","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T12:25:00Z","timestamp":1774873500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["UBC9-mediated SUMOylation of CORO1C drives lung adenocarcinoma progression via Arp2\/3-dependent cytoskeletal remodeling"],"prefix":"10.1038","volume":"17","author":[{"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6711-4016","authenticated-orcid":false,"given":"Juan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"8653_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"8653_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA Cancer J Clin"},{"key":"8653_CR3","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","volume":"20","author":"A Leiter","year":"2023","unstructured":"Leiter A, Veluswamy RR, Wisnivesky JP. The global burden of lung cancer: current status and future trends. Nat Rev Clin Oncol. 2023;20:624\u201339. https:\/\/doi.org\/10.1038\/s41571-023-00798-3.","journal-title":"Nat Rev Clin Oncol"},{"key":"8653_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41572-024-00551-9","volume":"10","author":"LEL Hendriks","year":"2024","unstructured":"Hendriks LEL, Remon J, Faivre-Finn C, Garassino MC, Heymach JV, Kerr KM, et al. Non-small-cell lung cancer. Nat Rev Dis Primers. 2024;10:71 https:\/\/doi.org\/10.1038\/s41572-024-00551-9.","journal-title":"Nat Rev Dis Primers"},{"key":"8653_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123146","volume":"358","author":"S Shi","year":"2024","unstructured":"Shi S, Wang C, Cai Q, Yang R, Peng M, Liang H, et al. RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability. Life Sci. 2024;358:123146. https:\/\/doi.org\/10.1016\/j.lfs.2024.123146.","journal-title":"Life Sci"},{"key":"8653_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13045-024-01637-3","volume":"17","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Zhang X, Lv Z, Huo H, Yuan L, Wan D, et al. Dynamically monitoring minimal residual disease using circulating tumour cells to predict the recurrence of early-stage lung adenocarcinoma. J Hematol Oncol. 2024;17:114. https:\/\/doi.org\/10.1186\/s13045-024-01637-3.","journal-title":"J Hematol Oncol"},{"key":"8653_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1097\/CM9.0000000000003341","volume":"138","author":"M Han","year":"2025","unstructured":"Han M, Wan F, Xiao B, Du J, Peng C, Peng F. Cell components of tumor microenvironment in lung adenocarcinoma: promising targets for small-molecule compounds. Chin Med J. 2025;138:905\u201315. https:\/\/doi.org\/10.1097\/CM9.0000000000003341.","journal-title":"Chin Med J"},{"key":"8653_CR8","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202500020RR","volume":"39","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Zhang Z, Cai Q, Yang R, Liang H, Qian B, et al. Lactylation increases the stability of RBM15 to drive m6A modification in non-small-cell lung cancer cells. FASEB J. 2025;39:e70493. https:\/\/doi.org\/10.1096\/fj.202500020RR.","journal-title":"FASEB J"},{"key":"8653_CR9","doi-asserted-by":"publisher","first-page":"4949","DOI":"10.1038\/onc.2016.24","volume":"35","author":"J Cai","year":"2016","unstructured":"Cai J, Zuo Y, Wang T, Cao Y, Cai R, Chen FL, et al. A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity. Oncogene. 2016;35:4949\u201356. https:\/\/doi.org\/10.1038\/onc.2016.24.","journal-title":"Oncogene"},{"key":"8653_CR10","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/nrm2293","volume":"8","author":"R Geiss-Friedlander","year":"2007","unstructured":"Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007;8:947\u201356. https:\/\/doi.org\/10.1038\/nrm2293.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8653_CR11","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1007\/s00018-007-7137-4","volume":"64","author":"J Zhao","year":"2007","unstructured":"Zhao J. Sumoylation regulates diverse biological processes. Cell Mol Life Sci. 2007;64:3017\u201333. https:\/\/doi.org\/10.1007\/s00018-007-7137-4.","journal-title":"Cell Mol Life Sci"},{"key":"8653_CR12","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3892\/ijo.2018.4280","volume":"52","author":"ZJ Han","year":"2018","unstructured":"Han ZJ, Feng YH, Gu BH, Li YM, Chen H. The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol. 2018;52:1081\u201394. https:\/\/doi.org\/10.3892\/ijo.2018.4280.","journal-title":"Int J Oncol"},{"key":"8653_CR13","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.cell.2007.08.045","volume":"131","author":"J Cheng","year":"2007","unstructured":"Cheng J, Kang X, Zhang S, Yeh ET. SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131:584\u201395. https:\/\/doi.org\/10.1016\/j.cell.2007.08.045.","journal-title":"Cell"},{"key":"8653_CR14","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/ijc.24286","volume":"125","author":"T Dunnebier","year":"2009","unstructured":"Dunnebier T, Bermejo JL, Haas S, Fischer HP, Pierl CB, Justenhoven C, et al. Common variants in the UBC9 gene encoding the SUMO-conjugating enzyme are associated with breast tumor grade. Int J Cancer. 2009;125:596\u2013602. https:\/\/doi.org\/10.1002\/ijc.24286.","journal-title":"Int J Cancer"},{"key":"8653_CR15","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.1038\/s41388-022-02431-6","volume":"41","author":"L Wei","year":"2022","unstructured":"Wei L, Wang W, Yao J, Cui Z, Xu Z, Ding H, et al. PACT promotes the metastasis of basal-like breast cancer through Rac1 SUMOylation and activation. Oncogene. 2022;41:4282\u201394. https:\/\/doi.org\/10.1038\/s41388-022-02431-6.","journal-title":"Oncogene"},{"key":"8653_CR16","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/onc.2009.459","volume":"29","author":"S Zhu","year":"2010","unstructured":"Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene. 2010;29:1763\u201372. https:\/\/doi.org\/10.1038\/onc.2009.459.","journal-title":"Oncogene"},{"key":"8653_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12957-025-03922-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li S, Xu Y, Chen Y, Xu C, He Q, et al. UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2. World J Surg Oncol. 2025;23:270. https:\/\/doi.org\/10.1186\/s12957-025-03922-y.","journal-title":"World J Surg Oncol"},{"key":"8653_CR18","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3892\/or.2013.2268","volume":"29","author":"H Li","year":"2013","unstructured":"Li H, Niu H, Peng Y, Wang J, He P. Ubc9 promotes invasion and metastasis of lung cancer cells. Oncol Rep. 2013;29:1588\u201394. https:\/\/doi.org\/10.3892\/or.2013.2268.","journal-title":"Oncol Rep"},{"key":"8653_CR19","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.tcb.2020.06.004","volume":"30","author":"S Seetharaman","year":"2020","unstructured":"Seetharaman S, Etienne-Manneville S. Cytoskeletal crosstalk in cell migration. Trends Cell Biol. 2020;30:720\u201335. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.004.","journal-title":"Trends Cell Biol"},{"key":"8653_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2024.108726","volume":"263","author":"S Mangaonkar","year":"2024","unstructured":"Mangaonkar S, Nath S, Chatterji BP. Microtubule dynamics in cancer metastasis: Harnessing the underappreciated potential for therapeutic interventions. Pharmacol Ther. 2024;263:108726. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108726.","journal-title":"Pharmacol Ther"},{"key":"8653_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41580-022-00508-4","volume":"23","author":"P Lappalainen","year":"2022","unstructured":"Lappalainen P, Kotila T, Jegou A, Romet-Lemonne G. Biochemical and mechanical regulation of actin dynamics. Nat Rev Mol Cell Biol. 2022;23:836\u201352. https:\/\/doi.org\/10.1038\/s41580-022-00508-4.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8653_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-025-08724-6","volume":"641","author":"H Schoofs","year":"2025","unstructured":"Schoofs H, Daubel N, Schnabellehner S, Gronloh MLB, Palacios Mart\u00ednez S, Halme A, et al. Dynamic cytoskeletal regulation of cell shape supports resilience of lymphatic endothelium. Nature. 2025;641:465\u201375. https:\/\/doi.org\/10.1038\/s41586-025-08724-6.","journal-title":"Nature"},{"key":"8653_CR23","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrm3861","volume":"15","author":"M Krause","year":"2014","unstructured":"Krause M, Gautreau A. Steering cell migration: lamellipodium dynamics and the regulation of directional persistence. Nat Rev Mol Cell Biol. 2014;15:577\u201390. https:\/\/doi.org\/10.1038\/nrm3861.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8653_CR24","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cell.2018.08.030","volume":"175","author":"MJ Hoyer","year":"2018","unstructured":"Hoyer MJ, Chitwood PJ, Ebmeier CC, Striepen JF, Qi RZ, Old WM, et al. A novel class of ER membrane proteins regulates ER-associated endosome fission. Cell. 2018;175:254\u201365.e14. https:\/\/doi.org\/10.1016\/j.cell.2018.08.030.","journal-title":"Cell"},{"key":"8653_CR25","doi-asserted-by":"publisher","unstructured":"King ZT, Butler MT, Hockenberry MA, Subramanian BC, Siesser PF, Graham DM, et al. Coro1B and Coro1C regulate lamellipodia dynamics and cell motility by tuning branched actin turnover. J Cell Biol. 2022;221. https:\/\/doi.org\/10.1083\/jcb.202111126.","DOI":"10.1083\/jcb.202111126"},{"key":"8653_CR26","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1016\/j.cell.2025.09.016","volume":"188","author":"W Oosterheert","year":"2025","unstructured":"Oosterheert W, Boiero Sanders M, Hofnagel O, Bieling P, Raunser S. Choreography of rapid actin filament disassembly by coronin, cofilin, and AIP1. Cell. 2025;188:6845\u201360.e27. https:\/\/doi.org\/10.1016\/j.cell.2025.09.016.","journal-title":"Cell"},{"key":"8653_CR27","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1038\/s41388-018-0422-x","volume":"37","author":"A Castagnino","year":"2018","unstructured":"Castagnino A, Castro-Castro A, Irondelle M, Guichard A, Lodillinsky C, Fuhrmann L, et al. Coronin 1C promotes triple-negative breast cancer invasiveness through regulation of MT1-MMP traffic and invadopodia function. Oncogene. 2018;37:6425\u201341. https:\/\/doi.org\/10.1038\/s41388-018-0422-x.","journal-title":"Oncogene"},{"key":"8653_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/neuonc\/nos388","volume":"15","author":"A Ziemann","year":"2013","unstructured":"Ziemann A, Hess S, Bhuwania R, Linder S, Kloppenburg P, Noegel AA, et al. CRN2 enhances the invasiveness of glioblastoma cells. Neuro Oncol. 2013;15:548\u201361. https:\/\/doi.org\/10.1093\/neuonc\/nos388.","journal-title":"Neuro Oncol"},{"key":"8653_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/srep00241","volume":"2","author":"CP Xavier","year":"2012","unstructured":"Xavier CP, Rastetter RH, Blomacher M, Stumpf M, Himmel M, Morgan RO, et al. Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2\/3 interaction and inhibits cell migration. Sci Rep. 2012;2:241. https:\/\/doi.org\/10.1038\/srep00241.","journal-title":"Sci Rep"},{"key":"8653_CR30","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.12659\/MSM.908929","volume":"24","author":"J Shao","year":"2018","unstructured":"Shao J, Zhang H, Wang Z. Coronin 1c and F-actin promote metastasis of breast cancer. Med Sci Monit. 2018;24:5980\u20137. https:\/\/doi.org\/10.12659\/MSM.908929.","journal-title":"Med Sci Monit"},{"key":"8653_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102237","volume":"99","author":"L Succony","year":"2021","unstructured":"Succony L, Rassl DM, Barker AP, McCaughan FM, Rintoul RC. Adenocarcinoma spectrum lesions of the lung: detection, pathology and treatment strategies. Cancer Treat Rev. 2021;99:102237. https:\/\/doi.org\/10.1016\/j.ctrv.2021.102237.","journal-title":"Cancer Treat Rev"},{"key":"8653_CR32","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1097\/JS9.0000000000002480","volume":"111","author":"W Zhao","year":"2025","unstructured":"Zhao W, Yang Z, Fei Q, Hu X, Ouyang Y, Yi X, et al. Treatment-related adverse events, immune-related adverse events and discontinuation in patients with solid tumors adding adjuvant immune checkpoint blockade: a meta-analysis of 38 randomized controlled trials. Int J Surg. 2025;111:4756\u201371. https:\/\/doi.org\/10.1097\/JS9.0000000000002480.","journal-title":"Int J Surg"},{"key":"8653_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44349-x","volume":"15","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Liang P, Meng H, Li F, Miao W, Chu C, et al. Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells. Nat Commun. 2024;15:40. https:\/\/doi.org\/10.1038\/s41467-023-44349-x.","journal-title":"Nat Commun"},{"key":"8653_CR34","doi-asserted-by":"publisher","unstructured":"Xiao J, Sun F, Wang YN, Liu B, Zhou P, Wang FX, et al. UBC9 deficiency enhances immunostimulatory macrophage activation and subsequent antitumor T cell response in prostate cancer. J Clin Investig. 2023;133. https:\/\/doi.org\/10.1172\/JCI158352.","DOI":"10.1172\/JCI158352"},{"key":"8653_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12929-024-01003-y","volume":"31","author":"CH Huang","year":"2024","unstructured":"Huang CH, Yang TT, Lin KI. Mechanisms and functions of SUMOylation in health and disease: a review focusing on immune cells. J Biomed Sci. 2024;31:16. https:\/\/doi.org\/10.1186\/s12929-024-01003-y.","journal-title":"J Biomed Sci"},{"key":"8653_CR36","doi-asserted-by":"publisher","unstructured":"Shi X, Du Y, Li S, Wu H. The role of SUMO E3 ligases in the signaling pathway of cancer cells. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms23073639.","DOI":"10.3390\/ijms23073639"},{"key":"8653_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189304","volume":"1880","author":"H Gao","year":"2025","unstructured":"Gao H, Sun F, Zhang X, Qiao X, Guo Y. The role and application of the Coronin family in human tumorigenesis and immunomodulation. Biochim Biophys Acta Rev Cancer. 2025;1880:189304. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189304.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8653_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.tcb.2011.04.004","volume":"21","author":"KT Chan","year":"2011","unstructured":"Chan KT, Creed SJ, Bear JE. Unraveling the enigma: progress towards understanding the coronin family of actin regulators. Trends Cell Biol. 2011;21:481\u20138. https:\/\/doi.org\/10.1016\/j.tcb.2011.04.004.","journal-title":"Trends Cell Biol"},{"key":"8653_CR39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nri3465","volume":"13","author":"J Pieters","year":"2013","unstructured":"Pieters J, Muller P, Jayachandran R. On guard: coronin proteins in innate and adaptive immunity. Nat Rev Immunol. 2013;13:510\u20138. https:\/\/doi.org\/10.1038\/nri3465.","journal-title":"Nat Rev Immunol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08653-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08653-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T22:26:02Z","timestamp":1778451962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08653-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8653"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08653-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirm that all methods were performed in accordance with relevant guidelines and regulations. All animal procedures were approved by the Experimental Animal Ethics Committee of the Second Xiangya Hospital, Central South University (Approval No. 2020377). Human study was approved by the Ethical Review Committee of the Second Xiangya Hospital, Central South University (Ethics approval No. LYEC2024-0033).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS STATEMENT"}}],"article-number":"434"}}